HOME |  IMPRINT |  DISCLAIMER |  CONTACT |  SITEMAP |  PRINT  

EBSA Events


15th Annual Conference of the European Biosafety Association

Manchester/UK
Workshops: 11 June 2012
Conference: 12 - 13 June 2012

5th Annual Conference of the European Biosafety Association, 2002

“National and Global Disease Outbreaks / Living with Bioterrorism”

Vienna, Austria

21 - 22 March 2002

 

Programme, Thursday, 21 March 2002

07.30 - 08.30 Registration
08.30 - 08.45 Welcome by EBSA President
Dr. Frank Verbeeck, Bristol-Myers Squibb, Belgium
08.45 - 12.30 Session I:

National and Global Disease Outbreaks
Living with Bio-terrorism

Chair: Prof. Dr. Franz X. Heinz, Institute of Virology, University of Vienna
08.45 - 09.30

The Control of Foot and Mouth Disease Virus Outbreak in the Netherlands:

The Role of Hygiene
Dr. A. Dekker, Head Laboratory Vesicular Diseases, ID Lelystad Institute for Animal Science and Health, The Netherlands
09.30 - 10.00 The Foot and Mouth Disease Epidemic in the UK 2001
10.00 - 10.30 Break / Exhibition
10.30 - 11.10

Bio-terrorism: Micro-organisms and Toxins as Weapons and Evaluation of Risk

Dr. Robert Hawley Ph.D.,
CBSP, Chief, Safety and Radiation Protection, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, USA
11.10 - 11.40

Global Outbreak Alert and Response

WHO's role in the fight against bio-terrrorism
Dr. Cathy Roth, Global Alert and Response Team, Dept of Surveillance and Response, Communicable Disease Cluster, WHO Geneva
11.40 - 12.15 Bio-terrorism - The Role of Irradiation as a Counter-measure to Bio-terrorism

Mr. Arnold Herer, Vice President of IBA Technology Group, Belgium
12.15 - 12.30 Panel Discussion

12.30 - 12.45

EBSA Honorary Membership
12.45 - 14.15 Lunch / Exhibition
14.15 - 17.20 Concurrent Session IIb

Biological Materials, Main Auditorium
15.00 - 17.00 Concurrent Session IIa

Transport of Biological Materials, Auditorium II
15.00 - 17.00 Concurrent Session IIa Transport of Biological Materials, Auditorium II

Chair Person: Mr. David J. Cocker,
MDCPartners Healthcare Consultants, Belgium
15.00 - 15.30 Future Directions: WHO Policy on Transport Biosafety

Dr. Nicoletta Previsani,
Department of Communicable Disease Surveillance and Response, WHO, Geneva
15.30 - 16.00 Break / Exhibition
16.00 - 16.30

CEN / ISO Standardisation Programme for Packaging of Infectious Substances

Mr. Maxence Wittebolle,
Belgian Packaging Institute, Brussels
16.30 - 17.00

Shipping: Training Responsibilities in Clinical Trials

Dr. Frank Verbeeck,
Bristol-Myers Squibb, Belgium

14.15 - 15.00

Concurrent Session IIb Pathogens Update, Main Auditorium

Chair Person: Mr. Martin Jones,
Pfizer, La Jolla, California, USA
14.15 - 15.00

HIV Emergence, Spread and Biosafety Aspects

Dr. Remi Van Den Broeck
Medical Director Medisearch Int., Belgium
15.00 - 15.30

The Polio Eradication Programme

Dr. David Wood,
Vaccines and Biologicals Department, WHO, Geneva
15.30 - 16.00 Break / Exhibition
16.00 - 16.40

Smallpox: Eradication, Virus Stocks and Bio-terrorism

Prof. Dr. Riccardo Wittek,
Institute for Animal Biology, Lausanne, Switzerland

16.40 - 17.10

Horizon Scanning: Outlook for 2002-2003,Arbovirus and Viral Haemorrhagic Fever an Overview

Dr. Hervé Zeller,
National Reference Centre for Arbovirus and Viral Haemorrhagic Fever, Institute Pasteur Lyon, France
17.10 - 17.20 Discussion
17.30 - 18.30

EBSA Annual General Meeting

EBSA Members Only, Main Auditorium
19.15

Evening Programme

Vienna by night: EBSA Annual Reception and Dinner
Sponsored by Novartis International, Basle, Switzerland
Departure: 19.15 hrs, Lobby Kaiser Franz Joseph Deraghotel

Friday, 22 March 2002

08.30 - 10.10 Session III Topics in Biosafety

Chair Person: Mr. Martin Jones,
Pfizer, La Jolla, California, USA
08.30 - 08.50 Microbiological Safety Cabinets - UK Perspective

Dr. John Newbold,
Health and Safety Executive, UK
08.50 - 09.10 Biohazard Courses for Maintenance Staff

Mr. Alan Kelly,
School of Biomedical Sciences, University of Leeds, UK
09.10- 09.30 The European Federation Biotechnology Task

Group Safety in Biotechnology - EBSA's Partner in Biotech Safety Issues

Prof. Dr. Otto Doblhoff,
Institute for Applied Microbiology, Vienna
09.30 - 10.10 Epidemiological Trends in Accidental Blood Exposure in European Countries

Dr. Arnaud Tarantola
GERES, Paris (Study Group on Risks of Blood Exposure)
10.10 - 11.00 Break
11.00 - 12.30 Session IV Regulatory Update

Chair Person: Prof. Dr. Helmut Bachmayer, Novartis
11.00 - 11.30 Reuse of Single Use Medical Devices - Risk and Regulations

Dr. Peter Schroeer
European Commission CEN
11.30 - 12.00 Deliberate Release of GMOs / Directive 2001/18/EC, Replacing Directive 90/220/EEC

Dr. Helmut Gaugitsch
Federal Environment Agency, Austria
12.00 - 12.30 The Joint European Enforcement Groups on the Contained Use of GMOs

Dr. Ursula Jenal,
Beratung Sicherheit, Switzerland
12.30 Closure - EBSA President:

Dr. Frank Verbeeck,
Bristol-Myers Squibb, Belgium